Skip to content
healthcare.dev

ivabradine

NDC 70710-1472, ivabradine, tablet, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1472
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213442
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1472 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IVABRADINE HYDROCHLORIDE7.5 mg/1

Pharmacologic classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]; Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC]

Package NDCNDC-11Package
70710-1472-67071014720660 TABLET in 1 BOTTLE (70710-1472-6)
70710-1472-870710147208180 TABLET in 1 BOTTLE (70710-1472-8)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/89134202-971b-4413-a9c9-d31a5c29722b
  • NADAC price for package 70710147206

    GET /v1/drugs/nadac/70710147206

Use it

Look up 70710-1472 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1472 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1472. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.